Tag Archives: ARQL

Hot Biotech Stocks To Invest In Right Now

Legend Biotech Co. (NASDAQ:LEGN)’s stock price gapped down prior to trading on Monday . The stock had previously closed at $37.39, but opened at $36.60. Legend Biotech shares last traded at $36.71, with a volume of 1,061 shares changing hands.

LEGN has been the subject of several analyst reports. Zacks Investment Research cut shares of Legend Biotech from a “hold” rating to a “sell” rating in a research report on Thursday, August 26th. JPMorgan Chase & Co. reiterated a “buy” rating on shares of Legend Biotech in a research report on Tuesday,....More>>>

Top 5 Biotech Stocks To Watch For 2023

AzurRx BioPharma, Inc. (AZRX Quick QuoteAZRX ) announced that it will rename itself as “First Wave BioPharma, Inc.” after the acquisition of a small biotech company, First Wave Bio, Inc.

The company acquired First Wave Bio in a stock and cash transaction valued at $229 million, which also includes potential milestone payments. The acquisition will be completed through a reverse triangular merger, according to the terms of the agreement.

Per an Investopedia article, in a reverse triangular merger, the acquiring company creates a new subsidiary company that purchases....More>>>

Best Biotech Stocks To Buy Right Now

What happened

For the second day in a row, biotech stock Berkeley Lights (NASDAQ:BLI) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an analyst tracking the stock issued a bullish new research note on the company, it continued to experience the fallout from a sharply worded tweet storm delivered by a short seller.

So what

Scorpion Capital’s six-tweet thread was published early on Wednesday, and it accused Berkeley Lights of “fleecing” both its customers and investors of its recent IPO.

The short seller said that....More>>>

Top Biotech Stocks To Invest In Right Now

Stocks finished lower Wednesday after minutes from the latest Federal Reserve meeting showed central bank officials believed more progress was needed in the employment market before it considered tapering stimulus but most said “it could be appropriate to start reducing the pace of asset purchases this year.

Here of some of the top stock gainers for Wednesday:

1. PharmaCyte Biotech | Increase 189%

PharmaCyte Biotech  (PMCB) – Get Report, which debuted on the Nasdaq last week, was skyrocketing as the chief executive laid out plans for the biotech company. 

PharmaCyte....More>>>

Top 10 Biotech Stocks To Buy For 2023

Amyris  (AMRS) – Get Report shares soared Friday after the biotech company announced promising in vivo results for a study of its licensed RNA vaccine for COVID through intranasal delivery.

The vaccine is being developed in collaboration with the Infectious Disease Research Institute, Amyris said.

Amyris recently traded at $13.67, up 13%.

“Current mRNA vaccine technologies are providing limited immunity protection for the upper respiratory system,” Amyris said. “As a result, vaccinated people may experience viral replication....More>>>